stars 1 stars 2 stars 3

BCAL Diagnostics is an Australian-owned, ASX listed, biotechnology company. They are pioneering and distributing non-invasive blood tests designed to provide patients with greater confidence in their care. BCAL believes early and accurate detection is key to improving cancer outcomes.

BCAL Diagnostics Questions

The BCAL Diagnostics annual revenue was $5.1 million in 2026.

Annie Arnett is the CEO of BCAL Diagnostics.

16 people are employed at BCAL Diagnostics.

BCAL Diagnostics is based in Eveleigh, New South Wales.

The NAICS codes for BCAL Diagnostics are [6215, 62151, 621, 62].

The SIC codes for BCAL Diagnostics are [80, 807].

Top BCAL Diagnostics Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users